CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY and 2…

Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY and 2 more

Read the official FDA notice

Published
30 Jul 2025
Units affected
3 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations; potential temperature excursions due to transit delays

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21

Brand / company
Mckesson Medical-Surgical Inc. Corporate Office
Codes / lots
Lot: 1178382, Expiration date: 3/31/2027 | Lot: YK4W, Expiration date: 4/30/2029 | Lot: 1180924, Expiration date: 6/30/2027.
Distribution
Within the U.S - OH, VA, FL.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.